• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多参数磁共振成像的影像组学列线图预测胶质母细胞瘤中端粒酶逆转录酶启动子突变及预后

Multi-parameter MRI based radiomics nomogram for predicting telomerase reverse transcriptase promoter mutation and prognosis in glioblastoma.

作者信息

Chen Ling, Chen Runrong, Li Tao, Tang Chuyun, Li Yao, Zeng Zisan

机构信息

Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Department of Radiology, Liuzhou Workers Hospital, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, China.

出版信息

Front Neurol. 2023 Sep 26;14:1266658. doi: 10.3389/fneur.2023.1266658. eCollection 2023.

DOI:10.3389/fneur.2023.1266658
PMID:37830090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10565857/
Abstract

OBJECTIVE

To investigate the clinical utility of multi-parameter MRI-based radiomics nomogram for predicting telomerase reverse transcriptase (TERT) promoter mutation status and prognosis in adult glioblastoma (GBM).

METHODS

We retrospectively analyzed MRI and pathological data of 152 GBM patients. A total of 2,832 radiomics features were extracted and filtered from preoperative MRI images. A radiomics nomogram was created on the basis of radiomics signature (rad-score) and clinical traits. The performance of the nomogram in TERT mutation identification was assessed using receiver operating characteristic (ROC) curve, calibration curves, and clinical decision curves. Pathologically confirmed TERT mutations and risk score-based TERT mutations were employed to assess patient prognosis, respectively.

RESULTS

The random forest (RF) algorithm outperformed the other two algorithms, yielding the best diagnostic efficacy in differentiating TERT mutations, with area under the curve (AUC) values of 0.892 (95% CI: 0.828-0.956) and 0.824 (95% CI: 0.677-0.971) in the training set and validation sets, respectively. Furthermore, the predictive power of the radiomics nomogram constructed with the rad-score and clinical variables reached 0.916 (95%CI: 0.864, 0.968) in the training set and 0.880 (95%CI: 0.743, 1) in the validation set. Calibration curve and decision curve analysis findings further uphold the clinical application value of the radiomics nomogram. The overall survival of the high-risk subgroup was significantly shorter than that of the low-risk subgroup, which was consistent with the results of the pathologically confirmed TERT mutation group.

CONCLUSION

The radiomics nomogram could non-invasively provide promising insights for predicting TERT mutations and prognosis in GBM patients with excellent identification and calibration abilities.

摘要

目的

探讨基于多参数磁共振成像(MRI)的影像组学列线图在预测成人胶质母细胞瘤(GBM)中端粒酶逆转录酶(TERT)启动子突变状态及预后方面的临床应用价值。

方法

回顾性分析152例GBM患者的MRI及病理数据。从术前MRI图像中提取并筛选出共2832个影像组学特征。基于影像组学特征(rad-score)和临床特征创建影像组学列线图。采用受试者工作特征(ROC)曲线、校准曲线和临床决策曲线评估列线图在TERT突变识别中的性能。分别采用病理确诊的TERT突变和基于风险评分的TERT突变评估患者预后。

结果

随机森林(RF)算法优于其他两种算法,在鉴别TERT突变方面具有最佳诊断效能,训练集和验证集的曲线下面积(AUC)值分别为0.892(95%CI:0.828 - 0.956)和0.824(95%CI:0.677 - 0.971)。此外,由rad-score和临床变量构建的影像组学列线图在训练集和验证集的预测能力分别达到0.916(95%CI:0.864,0.968)和0.880(95%CI:0.743,1)。校准曲线和决策曲线分析结果进一步支持了影像组学列线图的临床应用价值。高风险亚组的总生存期显著短于低风险亚组,这与病理确诊的TERT突变组结果一致。

结论

影像组学列线图能够无创地为预测GBM患者的TERT突变及预后提供有前景的见解,具有出色的识别和校准能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff00/10565857/a0fb45bdc2c6/fneur-14-1266658-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff00/10565857/3a759256f508/fneur-14-1266658-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff00/10565857/4f65f5452d2d/fneur-14-1266658-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff00/10565857/10ee89f1ae29/fneur-14-1266658-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff00/10565857/62f012e989e3/fneur-14-1266658-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff00/10565857/a0fb45bdc2c6/fneur-14-1266658-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff00/10565857/3a759256f508/fneur-14-1266658-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff00/10565857/4f65f5452d2d/fneur-14-1266658-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff00/10565857/10ee89f1ae29/fneur-14-1266658-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff00/10565857/62f012e989e3/fneur-14-1266658-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff00/10565857/a0fb45bdc2c6/fneur-14-1266658-g005.jpg

相似文献

1
Multi-parameter MRI based radiomics nomogram for predicting telomerase reverse transcriptase promoter mutation and prognosis in glioblastoma.基于多参数磁共振成像的影像组学列线图预测胶质母细胞瘤中端粒酶逆转录酶启动子突变及预后
Front Neurol. 2023 Sep 26;14:1266658. doi: 10.3389/fneur.2023.1266658. eCollection 2023.
2
A radiomics-based nomogram may be useful for predicting telomerase reverse transcriptase promoter mutation status in adult glioblastoma.基于放射组学的列线图可能有助于预测成人胶质母细胞瘤中端粒酶逆转录酶启动子突变状态。
Brain Behav. 2024 May;14(5):e3528. doi: 10.1002/brb3.3528.
3
Deep Learning Radiomics for the Assessment of Telomerase Reverse Transcriptase Promoter Mutation Status in Patients With Glioblastoma Using Multiparametric MRI.基于多参数MRI的深度学习影像组学用于评估胶质母细胞瘤患者端粒酶逆转录酶启动子突变状态
J Magn Reson Imaging. 2023 Nov;58(5):1441-1451. doi: 10.1002/jmri.28671. Epub 2023 Mar 10.
4
A radiomics feature-based nomogram to predict telomerase reverse transcriptase promoter mutation status and the prognosis of lower-grade gliomas.基于放射组学特征的列线图预测低级别胶质瘤端粒酶逆转录酶启动子突变状态和预后。
Clin Radiol. 2022 Aug;77(8):e560-e567. doi: 10.1016/j.crad.2022.04.005. Epub 2022 May 18.
5
Multiparametric MRI-based fusion radiomics for predicting telomerase reverse transcriptase (TERT) promoter mutations and progression-free survival in glioblastoma: a multicentre study.基于多参数 MRI 的融合放射组学预测胶质母细胞瘤中端粒酶逆转录酶(TERT)启动子突变和无进展生存期:一项多中心研究。
Neuroradiology. 2024 Jan;66(1):81-92. doi: 10.1007/s00234-023-03245-3. Epub 2023 Nov 17.
6
Peritumoral Radiomics for Identification of Telomerase Reverse Transcriptase Promoter Mutation in Patients With Glioblastoma Based on Preoperative MRI.基于术前 MRI 的胶质母细胞瘤患者端粒酶逆转录酶启动子突变的瘤周放射组学识别
Can Assoc Radiol J. 2024 Feb;75(1):143-152. doi: 10.1177/08465371231183309. Epub 2023 Aug 8.
7
The application of decision tree model based on clinicopathological risk factors and pre-operative MRI radiomics for predicting short-term recurrence of glioblastoma after total resection: a retrospective cohort study.基于临床病理危险因素和术前MRI影像组学的决策树模型在预测胶质母细胞瘤全切术后短期复发中的应用:一项回顾性队列研究
Am J Cancer Res. 2023 Aug 15;13(8):3449-3462. eCollection 2023.
8
A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.基于多参数 MRI 的放射组学列线图可根据生存情况对胶质母细胞瘤患者进行分层。
Eur Radiol. 2019 Oct;29(10):5528-5538. doi: 10.1007/s00330-019-06069-z. Epub 2019 Mar 7.
9
Noninvasive Prediction of TERT Promoter Mutations in High-Grade Glioma by Radiomics Analysis Based on Multiparameter MRI.基于多参数 MRI 的放射组学分析对高级别胶质瘤 TERT 启动子突变的无创预测
Biomed Res Int. 2020 May 15;2020:3872314. doi: 10.1155/2020/3872314. eCollection 2020.
10
MRI radiomics model for predicting TERT promoter mutation status in glioblastoma.MRI 放射组学模型预测胶质母细胞瘤 TERT 启动子突变状态。
Brain Behav. 2023 Dec;13(12):e3324. doi: 10.1002/brb3.3324. Epub 2023 Dec 6.

引用本文的文献

1
Nomogram prediction of molecular characteristics in WHO grade 3-4 diffuse gliomas based on fractal analysis and VASARI features.基于分形分析和VASARI特征的WHO 3-4级弥漫性胶质瘤分子特征的列线图预测
Sci Rep. 2025 May 3;15(1):15485. doi: 10.1038/s41598-025-00113-3.
2
Multiparametric MRI-based machine learning system of molecular subgroups and prognosis in medulloblastoma.基于多参数磁共振成像的髓母细胞瘤分子亚组和预后的机器学习系统
Eur Radiol. 2025 Jan 30. doi: 10.1007/s00330-025-11385-8.
3
Prognostic nomogram model based on quantitative metrics of subregions surrounding residual cavity in glioblastoma patients.

本文引用的文献

1
Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients.TERT 启动子状态、端粒长度和 MGMT 启动子甲基化在新诊断的 IDH 野生型胶质母细胞瘤患者中的预后作用和相互关系。
ESMO Open. 2023 Jun;8(3):101570. doi: 10.1016/j.esmoop.2023.101570. Epub 2023 May 23.
2
Deep Learning Radiomics for the Assessment of Telomerase Reverse Transcriptase Promoter Mutation Status in Patients With Glioblastoma Using Multiparametric MRI.基于多参数MRI的深度学习影像组学用于评估胶质母细胞瘤患者端粒酶逆转录酶启动子突变状态
J Magn Reson Imaging. 2023 Nov;58(5):1441-1451. doi: 10.1002/jmri.28671. Epub 2023 Mar 10.
3
基于胶质母细胞瘤患者残腔周围亚区定量指标的预后列线图模型。
J Cancer Res Clin Oncol. 2024 Nov 1;150(11):483. doi: 10.1007/s00432-024-06008-6.
4
Contrast-enhanced computed tomography-based radiomics nomogram for predicting HER2 status in urothelial bladder carcinoma.基于对比增强计算机断层扫描的影像组学列线图预测尿路上皮膀胱癌的HER2状态
Front Oncol. 2024 Aug 14;14:1427122. doi: 10.3389/fonc.2024.1427122. eCollection 2024.
5
Novel Imaging Approaches for Glioma Classification in the Era of the World Health Organization 2021 Update: A Scoping Review.世界卫生组织2021年更新时代下神经胶质瘤分类的新型成像方法:一项范围综述
Cancers (Basel). 2024 May 8;16(10):1792. doi: 10.3390/cancers16101792.
MRI radiomics and potential applications to glioblastoma.
磁共振成像放射组学及其在胶质母细胞瘤中的潜在应用。
Front Oncol. 2023 Feb 17;13:1134109. doi: 10.3389/fonc.2023.1134109. eCollection 2023.
4
Radiomic study on preoperative multi-modal magnetic resonance images identifies IDH-mutant TERT promoter-mutant gliomas.基于术前多模态磁共振图像的放射组学研究可识别 IDH 突变 TERT 启动子突变型胶质瘤。
Cancer Med. 2023 Feb;12(3):2524-2537. doi: 10.1002/cam4.5097. Epub 2022 Sep 29.
5
Adding radiomics to the 2021 WHO updates may improve prognostic prediction for current IDH-wildtype histological lower-grade gliomas with known EGFR amplification and TERT promoter mutation status.将放射组学加入到 2021 年 WHO 更新中,可能会提高当前 IDH 野生型组织学低级别胶质瘤的预后预测,这些胶质瘤已知 EGFR 扩增和 TERT 启动子突变状态。
Eur Radiol. 2022 Dec;32(12):8089-8098. doi: 10.1007/s00330-022-08941-x. Epub 2022 Jun 28.
6
Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma.结合术前磁共振成像的影像组学和深度卷积神经网络特征以预测胶质母细胞瘤中临床相关的遗传生物标志物。
Neurooncol Adv. 2022 Apr 22;4(1):vdac060. doi: 10.1093/noajnl/vdac060. eCollection 2022 Jan-Dec.
7
A radiomics feature-based nomogram to predict telomerase reverse transcriptase promoter mutation status and the prognosis of lower-grade gliomas.基于放射组学特征的列线图预测低级别胶质瘤端粒酶逆转录酶启动子突变状态和预后。
Clin Radiol. 2022 Aug;77(8):e560-e567. doi: 10.1016/j.crad.2022.04.005. Epub 2022 May 18.
8
Major Features of the 2021 WHO Classification of CNS Tumors.2021 年世界卫生组织中枢神经系统肿瘤分类的主要特征。
Neurotherapeutics. 2022 Oct;19(6):1691-1704. doi: 10.1007/s13311-022-01249-0. Epub 2022 May 16.
9
TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo.神经祖细胞中的 TERT 启动子 C228T 突变赋予了体内端粒缩短后的生长优势。
Neuro Oncol. 2022 Dec 1;24(12):2063-2075. doi: 10.1093/neuonc/noac080.
10
A Multiparametric MRI-Based Radiomics Nomogram for Preoperative Prediction of Survival Stratification in Glioblastoma Patients With Standard Treatment.基于多参数磁共振成像的影像组学列线图用于胶质母细胞瘤标准治疗患者术前生存分层预测
Front Oncol. 2022 Feb 16;12:758622. doi: 10.3389/fonc.2022.758622. eCollection 2022.